BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Mu X, Zhao Q, Chen W, Zhao Y, Yan Q, Peng R, Zhu J, Yang C, Lan K, Gu X, Wang Y. IL-37 Confers Anti-Tumor Activity by Regulation of m6A Methylation. Front Oncol 2020;10:526866. [PMID: 33489865 DOI: 10.3389/fonc.2020.526866] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Su Z, Tao X. Current Understanding of IL-37 in Human Health and Disease. Front Immunol 2021;12:696605. [PMID: 34248996 DOI: 10.3389/fimmu.2021.696605] [Reference Citation Analysis]
2 Ma C, Ma RJ, Hu K, Zheng QM, Wang YP, Zhang N, Sun ZG. The molecular mechanism of METTL3 promoting the malignant progression of lung cancer. Cancer Cell Int 2022;22:133. [PMID: 35331234 DOI: 10.1186/s12935-022-02539-5] [Reference Citation Analysis]
3 Cheng Y, Wang M, Zhou J, Dong H, Wang S, Xu H. The Important Role of N6-methyladenosine RNA Modification in Non-Small Cell Lung Cancer. Genes (Basel) 2021;12:440. [PMID: 33808751 DOI: 10.3390/genes12030440] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
4 Wang Y, Su X, Zhao M, Xu M, Chen Y, Li Z, Zhuang W. Importance of N6-methyladenosine RNA modification in lung cancer (Review). Mol Clin Oncol 2021;14:128. [PMID: 33981432 DOI: 10.3892/mco.2021.2290] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]